Abstract
The turnstile motion of two neighboring threonines sets up a dynamic side chain interplay that can accommodate both polar and apolar ligands in a small molecule allosteric protein binding site. A computational model based on SAR data and both X-ray and cryo-EM structures of the AAA ATPase p97 was used to analyze the effects of paired threonines at the inhibitor site. Specifically, the Thr side chain hydroxyl groups form a hydrogen bonding network that readily accommodates small, highly polar ligand substituents. Conversely, diametric rotation of the χ1 torsion by 150-180° orients the side chain β-methyl groups into the binding cleft, creating a hydrophobic pocket that can accommodate small, apolar substituents. This motif was found to be critical for rationalizing the affinities of a structurally focused set of inhibitors of p97 covering a > 2000-fold variation in potencies, with a preference for either small-highly polar or small-apolar groups. The threonine turnstile motif was further validated by a PDB search that identified analogous binding modes in ligand interactions in PKB, as well as by an analysis of NMR structures demonstrating additional gear-like interactions between adjacent Thr pairs. Combined, these data suggest that the threonine turnstile motif may be a general feature of interest in protein binding pockets.
| Original language | English |
|---|---|
| Pages (from-to) | 4096-4114 |
| Number of pages | 19 |
| Journal | Organic and Biomolecular Chemistry |
| Volume | 15 |
| Issue number | 19 |
| DOIs | |
| State | Published - 16 May 2017 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2017 The Royal Society of Chemistry.
Funding
This project was funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Chemical Biology Consortium Contract No. HHSN261200800001E Agreement No. 29XS127TO15.
| Funders | Funder number |
|---|---|
| National Institutes of Health | 29XS127TO15 |
| National Institute on Aging | R01AG044515 |
| National Cancer Institute |